Overall, our findings suggest that Tregs in CML BM preferentially interact with CD8+ CTLs and regulate their function instead of interacting directly with CML stem/progenitor cells — findings that are supported by functional data generated in this study. This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.